Therapeutic nanoparticles in clinics and under clinical evaluation.
Détails
ID Serval
serval:BIB_A4D26E191D54
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Therapeutic nanoparticles in clinics and under clinical evaluation.
Périodique
Nanomedicine
Collaborateur⸱rice⸱s
NanoImpactNet Consortium
ISSN
1748-6963 (Electronic)
ISSN-L
1743-5889
Statut éditorial
Publié
Date de publication
03/2013
Peer-reviewed
Oui
Volume
8
Numéro
3
Pages
449-467
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
This article reviews nanoparticulate-chemotherapeutic systems that have been developed for human therapy, considering the components of the nanoparticles, the therapeutic agents associated with the nanoparticles and the clinical indications these therapeutic nanoparticles have been developed for. In this evaluation we have put into perspective the types of nanomaterials and their therapeutic indications. We have reviewed the nanoparticulate-chemotherapeutic systems that have been published, approved and marketed and that are currently in clinical use. We have also analyzed the nanoparticulate-chemotherapeutic systems that are in clinical trials and under preclinical development.
Mots-clé
Clinical Trials as Topic, Drug Delivery Systems/adverse effects, Drug Evaluation, Preclinical, Drug Therapy, Gold/adverse effects, Gold/chemistry, Gold/therapeutic use, Humans, Metal Nanoparticles/adverse effects, Metal Nanoparticles/therapeutic use
Pubmed
Web of science
Création de la notice
28/03/2013 17:23
Dernière modification de la notice
20/08/2019 16:10
Données d'usage
